|
DCP1B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.915500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.309400E-01 |
| Normal-vs-Stage2 |
4.066000E-01 |
| Normal-vs-Stage3 |
2.162000E-02 |
| Normal-vs-Stage4 |
4.084200E-01 |
| Stage1-vs-Stage2 |
8.317600E-01 |
| Stage1-vs-Stage3 |
1.425640E-01 |
| Stage1-vs-Stage4 |
7.497000E-01 |
| Stage2-vs-Stage3 |
1.711770E-01 |
| Stage2-vs-Stage4 |
6.345000E-01 |
| Stage3-vs-Stage4 |
5.785600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.954100E-02 |
| Normal-vs-AfricanAmerican |
2.379400E-03 |
| Normal-vs-Asian |
7.693000E-01 |
| Caucasian-vs-AfricanAmerican |
1.530420E-01 |
| Caucasian-vs-Asian |
7.742400E-01 |
| AfricanAmerican-vs-Asian |
4.069800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.724200E-02 |
| Normal-vs-Female |
2.116500E-03 |
| Male-vs-Female |
8.376100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.370400E-02 |
| Normal-vs-Extreme_Weight |
6.072400E-01 |
| Normal-vs-Obese |
3.820500E-03 |
| Normal-vs-Extreme_Obese |
6.311000E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.004200E-01 |
| Normal_Weight-vs-Obese |
5.383400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.681000E-01 |
| Extreme_Weight-vs-Obese |
3.026000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.704400E-01 |
| Obese-vs-Extreme_Obese |
5.910400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.081400E-03 |
| Normal-vs-Age(41-60Yrs) |
2.595400E-04 |
| Normal-vs-Age(61-80Yrs) |
3.374600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.326800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.339000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.461600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.400400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.496200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.385230E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.222400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.260120E-03 |
| Normal-VS-Type2 PRCC |
5.977000E-01 |
| Normal-VS-KIRP CIMP |
4.464200E-01 |
| Normal-VS-Unclassified PRCC |
2.621900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.205900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.792800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.406800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.555200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.275600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.319800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.268200E-01 |
| Normal-vs-N1 |
2.564500E-03 |
| Normal-vs-N2 |
2.754000E-01 |
| N0-vs-N1 |
4.676100E-03 |
| N0-vs-N2 |
2.464000E-01 |
| N1-vs-N2 |
8.078200E-01 |
|
|
